CFO of Array BioPharma Inc. (ARRY, Financial) Michael Carruthers sells 1,225 shares of ARRY on 10/12/2010 at an average price of $3.32 a share.
Array Biopharma Inc. has a market cap of $188.2 million; its shares were traded at around $3.52 with and P/S ratio of 3.5. Array Biopharma Inc. had an annual average earning growth of 20.9% over the past 10 years.
ARRY is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Jean-Marie Eveillard of First Eagle Investment Management, LLC, Jim Simons of Renaissance Technologies LLC.
Array Biopharma Inc. has a market cap of $188.2 million; its shares were traded at around $3.52 with and P/S ratio of 3.5. Array Biopharma Inc. had an annual average earning growth of 20.9% over the past 10 years.
ARRY is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Jean-Marie Eveillard of First Eagle Investment Management, LLC, Jim Simons of Renaissance Technologies LLC.
CFO Recent Trades:
- Sell: CFO Michael Carruthers sold 1,415 shares of ARRY stock on 09/14/2010 at the average price of 2.88. Michael Carruthers owns at least 70,353 shares after this. The price of the stock has increased by 22.22% since.
- Sell: CFO Michael Carruthers sold 17 shares of ARRY stock on 08/23/2010 at the average price of 2.79. Michael Carruthers owns at least 71,768 shares after this. The price of the stock has increased by 26.16% since.
- Sell: CFO Michael Carruthers sold 1,309 shares of ARRY stock on 07/23/2010 at the average price of 3.11. Michael Carruthers owns at least 71,785 shares after this. The price of the stock has increased by 13.18% since.
- Sell: CFO Michael Carruthers sold 1,208 shares of ARRY stock on 06/23/2010 at the average price of 3.37. Michael Carruthers owns at least 73,094 shares after this. The price of the stock has increased by 4.45% since.
- Sell: CFO Michael Carruthers sold 1,183 shares of ARRY stock on 05/21/2010 at the average price of 3.44. Michael Carruthers owns at least 74,302 shares after this. The price of the stock has increased by 2.33% since.
Directors and Officers Recent Trades:
- Buy: Director Kyle Lefkoff bought 4,000 shares of ARRY stock on 05/07/2010 at the average price of 3.71. Kyle Lefkoff owns at least 54,585 shares after this. The price of the stock has decreased by 5.12% since.
- Sell: VP, General Counsel John R Moore sold 20,067 shares of ARRY stock on 10/05/2010 at the average price of 3.29. John R Moore owns at least 27,354 shares after this. The price of the stock has increased by 6.99% since.
- Sell: VP, General Counsel John R Moore sold 6,319 shares of ARRY stock on 08/03/2010 at the average price of 3.25. John R Moore owns at least 21,317 shares after this. The price of the stock has increased by 8.31% since.
- Sell: Director Marvin H Caruthers sold 1,650 shares of ARRY stock on 06/08/2010 at the average price of 3.12. Marvin H Caruthers owns at least 449,234 shares after this. The price of the stock has increased by 12.82% since.
